【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 16
2 Introduction 17
2.1 Cardiovascular Surgery Devices Overview 17
3 Products under Development 19
3.1 Cardiovascular Surgery Devices – Pipeline Products by Stage of Development 19
3.2 Cardiovascular Surgery Devices – Pipeline Products by Segment 20
3.3 Cardiovascular Surgery Devices – Pipeline Products by Territory 21
3.4 Cardiovascular Surgery Devices – Pipeline Products by Regulatory Path 23
3.5 Cardiovascular Surgery Devices – Pipeline Products by Estimated Approval Date 24
3.6 Cardiovascular Surgery Devices – Ongoing Clinical Trials 25
4 Cardiovascular Surgery Devices – Pipeline Products under Development by Companies 26
4.1 Cardiovascular Surgery Devices Companies – Pipeline Products by Stage of Development 26
4.2 Cardiovascular Surgery Devices – Pipeline Products by Stage of Development 30
5 Cardiovascular Surgery Devices Companies and Product Overview 34
5.1 3S BioMedical, Inc. Company Overview 34
5.1.1 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.2 AblaCor Medical Corporation Company Overview 35
5.2.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 35
5.3 Advanced Catheter Therapies, Inc. Company Overview 36
5.3.1 Advanced Catheter Therapies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.4 AdvanSource Biomaterials Corporation Company Overview 38
5.4.1 AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 38
5.5 AFreeze GmbH Company Overview 42
5.5.1 AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview 42
5.6 Anethon (Inactive) Company Overview 47
5.6.1 Anethon (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 47
5.7 AngioDynamics, Inc. Company Overview 48
5.7.1 AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.8 Apaxis Medical, Inc. Company Overview 51
5.8.1 Apaxis Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.9 APK Advanced Medical Technologies, Inc. Company Overview 55
5.9.1 APK Advanced Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.10 Arterion AB Company Overview 56
5.10.1 Arterion AB Pipeline Products & Ongoing Clinical Trials Overview 56
5.11 AtriCure, Inc. Company Overview 57
5.11.1 AtriCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.12 Axcelon Biopolymers Corp. Company Overview 61
5.12.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 61
5.13 Beth Israel Deaconess Medical Center, Inc. Company Overview 62
5.13.1 Beth Israel Deaconess Medical Center, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.14 Bioretec Ltd. Company Overview 64
5.14.1 Bioretec Ltd. Pipeline Products & Ongoing Clinical Trials Overview 64
5.15 Boston University Company Overview 65
5.15.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 65
5.16 CardioPolymers, Inc. Company Overview 67
5.16.1 CardioPolymers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.17 CardioPrecision Ltd Company Overview 68
5.17.1 CardioPrecision Ltd Pipeline Products & Ongoing Clinical Trials Overview 68
5.18 CardioScout, LLC Company Overview 69
5.18.1 CardioScout, LLC Pipeline Products & Ongoing Clinical Trials Overview 69
5.19 CellProthera Company Overview 70
5.19.1 CellProthera Pipeline Products & Ongoing Clinical Trials Overview 70
5.20 Children’s Hospital Boston Company Overview 72
5.20.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 72
5.21 Circulatory Technology Inc. Company Overview 74
5.21.1 Circulatory Technology Inc. Pipeline Products & Ongoing Clinical Trials Overview 74
5.22 Cleveland Clinic Hospital Company Overview 75
5.22.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 75
5.23 Corazon Technologies, Inc. Company Overview 77
5.23.1 Corazon Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.24 CorMatrix Cardiovascular, Inc. Company Overview 78
5.24.1 CorMatrix Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.25 Coromedic Ltd. Company Overview 81
5.25.1 Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 81
5.26 CPSI Biotech Company Overview 83
5.26.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 83
5.27 Cytograft Tissue Engineering, Inc. Company Overview 84
5.27.1 Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 84
5.28 Design Mentor, Inc. Company Overview 88
5.28.1 Design Mentor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
5.29 Edwards Lifesciences Corporation Company Overview 89
5.29.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 89
5.30 Elana bv Company Overview 91
5.30.1 Elana bv Pipeline Products & Ongoing Clinical Trials Overview 91
5.31 Emory University Company Overview 92
5.31.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 92
5.32 Endogene Ltd Company Overview 94
5.32.1 Endogene Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
5.33 EpiEP, Inc. Company Overview 97
5.33.1 EpiEP, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
5.34 European Medical Contract Manufacturing B.V. Company Overview 98
5.34.1 European Medical Contract Manufacturing B.V. Pipeline Products & Ongoing Clinical Trials Overview 98
5.35 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung e.V. Company Overview 99
5.35.1 Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung e.V. Pipeline Products & Ongoing Clinical Trials Overview 99
5.36 Graft-Loc Inc. Company Overview 100
5.36.1 Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview 100
5.37 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 101
5.37.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 101
5.38 Harpoon Medical, Inc. Company Overview 103
5.38.1 Harpoon Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 103
5.39 HeartLander Surgical, Inc. Company Overview 106
5.39.1 HeartLander Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 106
5.40 Helical Solutions, Inc. Company Overview 107
5.40.1 Helical Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 107
5.41 Hocor Cardiovascular Technologies, LLC Company Overview 108
5.41.1 Hocor Cardiovascular Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 108
5.42 iiTech BV Company Overview 109
5.42.1 iiTech BV Pipeline Products & Ongoing Clinical Trials Overview 109
5.43 Kardium Inc. Company Overview 112
5.43.1 Kardium Inc. Pipeline Products & Ongoing Clinical Trials Overview 112
5.44 Kips Bay Medical, Inc. Company Overview 116
5.44.1 Kips Bay Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 116
5.45 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 118
5.45.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 118
5.46 LivaNova PLC Company Overview 119
5.46.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 119
5.47 LuxCath, LLC Company Overview 126
5.47.1 LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview 126
5.48 Magenta Medical Inc Company Overview 127
5.48.1 Magenta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 127
5.49 Mayo Clinic. Company Overview 128
5.49.1 Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview 128
5.50 MedArray Inc. Company Overview 129
5.50.1 MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 129
5.51 Medrobotics Corporation Company Overview 132
5.51.1 Medrobotics Corporation Pipeline Products & Ongoing Clinical Trials Overview 132
5.52 Medtronic plc Company Overview 134
5.52.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 134
5.53 Michigan Critical Care Consultants, Inc. Company Overview 136
5.53.1 Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 136
5.54 MicroPort Scientific Corporation Company Overview 137
5.54.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 137
5.55 Neograft Technologies, Inc. Company Overview 139
5.55.1 Neograft Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 139
5.56 Nipro Corporation Company Overview 142
5.56.1 Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview 142
5.57 Northwestern University Company Overview 145
5.57.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 145
5.58 NovelMed Therapeutics, Inc. Company Overview 148
5.58.1 NovelMed Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 148
5.59 Novogate Medical Ltd. Company Overview 149
5.59.1 Novogate Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 149
5.60 NuPulse Inc Company Overview 150
5.60.1 NuPulse Inc Pipeline Products & Ongoing Clinical Trials Overview 150
5.61 NuVascular Technologies Inc Company Overview 151
5.61.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 151
5.62 Prekubator TTO Company Overview 152
5.62.1 Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview 152
5.63 Protego Medical Pty Ltd Company Overview 153
5.63.1 Protego Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 153
5.64 Rafael Medical Technologies, Inc. Company Overview 154
5.64.1 Rafael Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 154
5.65 Replication Medical, Inc. Company Overview 155
5.65.1 Replication Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 155
5.66 Revivicor, Inc. Company Overview 157
5.66.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 157
5.67 SeamVad Ltd. Company Overview 158
5.67.1 SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview 158
5.68 SentreHEART, Inc. Company Overview 160
5.68.1 SentreHEART, Inc. Pipeline Products & Ongoing Clinical Trials Overview 160
5.69 Sorin S.p.A. (Inactive) Company Overview 163
5.69.1 Sorin S.p.A. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 163
5.70 Southern Research Institute Company Overview 166
5.70.1 Southern Research Institute Pipeline Products & Ongoing Clinical Trials Overview 166
5.71 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 167
5.71.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 167
5.72 St. Jude Medical, Inc. Company Overview 171
5.72.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 171
5.73 Stanford University Company Overview 173
5.73.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 173
5.74 Synovis Life Technologies, Inc. Company Overview 175
5.74.1 Synovis Life Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 175
5.75 Tengion, Inc. (Inactive) Company Overview 176
5.75.1 Tengion, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 176
5.76 The Johns Hopkins University Company Overview 178
5.76.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 178
5.77 The Spectranetics Corporation Company Overview 180
5.77.1 The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview 180
5.78 The University of Utah Company Overview 182
5.78.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 182
5.79 Theracardia Company Overview 184
5.79.1 Theracardia Pipeline Products & Ongoing Clinical Trials Overview 184
5.80 Thermedical, Inc. Company Overview 185
5.80.1 Thermedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 185
5.81 Tissue Regeneration Technologies, LLC Company Overview 187
5.81.1 Tissue Regeneration Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 187
5.82 Trivitron Healthcare Pvt Ltd. Company Overview 189
5.82.1 Trivitron Healthcare Pvt Ltd. Pipeline Products & Ongoing Clinical Trials Overview 189
5.83 Tufts Medical Center Company Overview 190
5.83.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview 190
5.84 Universite de Montreal Company Overview 191
5.84.1 Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview 191
5.85 University College London Company Overview 193
5.85.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 193
5.86 University of Arizona Company Overview 194
5.86.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 194
5.87 University of California, Los Angeles Company Overview 196
5.87.1 University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 196
5.88 University of Nebraska Company Overview 199
5.88.1 University of Nebraska Pipeline Products & Ongoing Clinical Trials Overview 199
5.89 University of Pittsburgh Company Overview 200
5.89.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 200
5.90 University of Strathclyde Company Overview 202
5.90.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 202
5.91 Vanderbilt University Company Overview 203
5.91.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 203
5.92 Veniti, Inc. Company Overview 205
5.92.1 Veniti, Inc. Pipeline Products & Ongoing Clinical Trials Overview 205
5.93 Ventrica, Inc. Company Overview 206
5.93.1 Ventrica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 206
5.94 VytronUS, Inc. Company Overview 207
5.94.1 VytronUS, Inc. Pipeline Products & Ongoing Clinical Trials Overview 207
5.95 W-Z BIOTECH, LLC Company Overview 208
5.95.1 W-Z BIOTECH, LLC Pipeline Products & Ongoing Clinical Trials Overview 208
6 Cardiovascular Surgery Devices- Recent Developments 210
7 Appendix 339
7.1 Methodology 339
7.2 About GlobalData 341
7.3 Contact Us 342
7.4 Disclaimer 342
【レポート販売概要】
■ タイトル：世界の心血管手術機器開発動向：医療機器パイプライン分析2015■ 英文：Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月5日
■ 調査会社：GlobalData
■ 商品コード：GDME0141EPD
■ 調査対象地域：グローバル
- 籾殻灰の世界市場予測（～2020）The global rice husk ash market is estimated to reach USD 2.42 Billion by 2020, at a CAGR of 5.15% between 2015 and 2020. Factors, such as growth of various end user industries and increase in the demand for light weight construction material from the building & construction industry are expected to drive the global rice husk ash market during the forecast period, from 2015 to 2020. The building & …
- バイオシミュレーションの世界市場分析：製品別（ソフトウェア、サービス、社内サービス、契約サービス）、用途別（薬の開発、薬の発見）、エンドユーザー別（医薬品・バイオテクノロジー企業、CRO、規制当局、学術研究機関）、セグメント予測The biosimulation market is expected to reach USD 3.77 billion by 2024, according to a new study by Grand View Research, Inc. The unprecedented global shift in the adoption of unhealthy lifestyles is resulting in the high prevalence of chronic diseases, such as cancer and diabetes, is expected to drive the biosimulation market during the forecast period. In addition, the rising geriatric populatio …
- 無人潜水機（UUV）の世界市場：遠隔操作無人探査機（ROV）、自律型無人潜水機（AUV）The Unmanned underwater vehicle (UUV) market is projected to grow from USD 2.29 Billion in 2015 to USD 4.00 Billion by 2020, at a CAGR of 11.90% during the forecast period. Factors, such as increase need for deep water offshore oil and gas production, maritime security and threats, need for ocean data and mapping are the major factors which will drive the unmanned underwater vehicle market. UUVs h …
- 装甲車の世界市場2015-2025Visiongain assesses that the global demand for military armoured vehicles will reach $12.4bn in 2015. Armoured vehicles have always been a key component of military ground forces. This armoured vehicle market report looks at demand for military vehicles that are designed to withstand some level of hostile fair and also resistance to mines and improvised explosive devices (IEDs). Armoured vehicles …
- バイオマーカーの世界市場予測（～2021年）：安全性マーカー、予測マーカー、代替マーカー、薬力学マーカー、予後マーカーThe global biomarkers market is estimated to reach USD 53.34 billion by 2021 from USD 27.95 billion in 2016, at a CAGR of 13.8% from 2016 to 2021.Increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries, the high prevalence of cancer, and new initiatives for biomarker …
- 医薬品契約販売の世界市場2016-2026Outsourced Medical Sales – How to Find Pharma Trends, Opportunities and Potential RevenuesAre you interested in the future of outsourced pharmaceutical sales? If so, gain new multilevel forecasts for those promotional activities. With our updated report, stay ahead in data on contract sales organisations (CSOs). See what revenues are possible. Also assess changes sweeping that industry. Avoid gett …
- 企業エンドポイント・サイバーセキュリティの世界市場2015-2020This new report offers comprehensive analysis of enterprise endpoint cyber security solutions and related companies. Visiongain assesses that the enterprise endpoint cyber security market will reach $4.98bn in 2015. Visiongain’s report will ensure that you keep informed and ahead of your competitors. Gain that competitive advantage. The report will answer questions such as: • How is the Enterprise …
- 世界のセルフチェックアウトターミナル市場動向（2012-2016）TechNavio's analysts forecast the Global Self-checkout Terminals market to grow at a CAGR of 15.1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the reduction in queue size during the time of checkout. The Global Self-checkout Terminals market has also been witnessing the evolution of small size self-checkout terminals. However, the increased chance …
- ティッシュペーパーの世界市場2015-2019About Tissue Paper Tissue paper, an essential hygiene and sanitary product, has gained worldwide acceptance and stands out as an indispensable sanitation enabler today. The raw material used for the production of tissue paper is paper pulp. Among all the qualities of a tissue paper, its absorbency and strength hold the utmost importance. Though the western markets already have an established marke …
- パーライト及びバーミキュライトの世界市場動向2014/2015The report presents a thorough study of perlite and vermiculite, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing perlite and vermiculite worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: perlite and vermicu …
- 薬局オートメーションの世界市場予測（～2022年）：薬剤分注装置、包装・ラベル装置、計数装置、保管装置The pharmacy automation market is expected to grow at a lucrative CAGR of 8.2% from 2017 to 2022, to reach USD 5.38 billion by 2022 from USD 3.63 billion in 2017. The growth in pharmacy automation market is primarily due to the increased focus on reducing medication errors, increased burden on pharmacies due to rising geriatric population, rapid decentralization of pharmacies, and rising labor cos …
- くい打ち機の世界市場2016-2020About the Pile Driving Equipment Market Prior to the start of construction, the soil is analyzed for load-bearing capacity. Deep foundations are essential when the soil is not stable to sustain heavy loads. The depth of the foundation is calculated by the extent of stability of the soil present under the ground surface. Pile foundation maintains safety in multi-story buildings and provides reinfor …
- 世界の紙コーティング材料市場動向（～2019）The paper coating materials market was estimated to be $6.5 Billion in 2013, with the highest share of more than 50% held by the Asia-Pacific and ROW together. The global market is projected to grow at a CAGR of 2.5% from 2014 to 2019. The highest investment is forecasted to be in the Asia-Pacific due to the growing application markets and availability of raw materials, especially in China. ROW is …
- リアルタイム決済（RTP）の世界市場予測（～2023年）The global Real-Time Payments (RTP) market is estimated to grow at a Compound Annual Growth Rate (CAGR) of 30.6% during the forecast periodMarketsandMarkets forecasts the global RTP market size to grow from USD 6.8 billion in 2018 to USD 25.9 billion by 2023, at a CAGR of 30.6% during the forecast period. The major growth factors expected to drive the growth of the RTP market include the high prol …
- プラスチック用酸化防止剤の世界市場予測（～2022年）The plastic antioxidants market is estimated to reach USD 2.11 Billion by 2022, at a CAGR of 4.5% between 2017 and 2022. The growth of the market is driven by the replacement of conventional materials by plastics in various industries, and the increasing disposable income and rapid urbanization in emerging countries. The usage of plastic antioxidants is estimated to be highest in Polypropylene (PP …
